Physician profile
Christopher Hatch
NPI 1104507730
$1,337.07
in general payments reported to CMS, 2019-2025
16 companies · $867 in 2025
The $867 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $470 · 2025: $867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,337.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $222.54 | 2024-2025 | Airsupra, Breztri |
| Novo Nordisk INC | $167.66 | 2024-2025 | Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $163.21 | 2024-2025 | Rexulti |
| Xeris Pharmaceuticals, INC. | $108.82 | 2024-2025 | Gvoke Hypopen |
| Lilly USA, LLC | $101.05 | 2024-2025 | Mounjaro, Zepbound, Amyvid |
| Boston Scientific Corporation | $91.63 | 2025 | Watchman Flx |
| Scpharmaceuticals INC. | $88.03 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $80.19 | 2024-2025 | Voquezna |
| Merck Sharp & Dohme LLC | $75.79 | 2024-2025 | Verquvo |
| Exact Sciences Corporation | $58.58 | 2025 | Cologuard Collection Kit |
| Actelion Pharmaceuticals US, INC. | $45.33 | 2024-2025 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.81 | 2024-2025 | Jardiance |
| Lundbeck LLC | $26.46 | 2024 | Rexulti |
| Paratek Pharmaceuticals, INC. | $22.58 | 2025 | Nuzyra |
| Bayer Healthcare Pharmaceuticals INC. | $22.11 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.28 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hatch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.